Oncology / Gynecologic Newest Continuing Medical Education Live Events, Webcasts & Online Activities

Oncology Best Practice™: Honing Patient Management Approaches with PARP Inhibition in Ovarian Cancer: What Nurses Need to Know

10/31/2020 - 10/31/2021

Chair: Paula Anastasia RN, MN, AOCN

1.0 CNE

Oncology Briefings: Assessing the Role of BTK Inhibitors Across Hematologic Malignancies

Expires on 02/26/2022

Chaitra Ujjani, MD

1.0 CME

25th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

02/25/2021 - 02/28/2021

Virtual Conference

Co-Chairs: Andre Goy, MD; Jorge E. Cortes, MD; Sagar Lonial, MD, FACP

21.75 CME

21.75 CNE

Virtual Tumor Board®: Exploring the Practicalities of Gynecologic Cancer Management As New Options Emerge

Expires on 02/26/2022

Ursula A. Matulonis, MD; Robert L. Coleman, MD, FACOG, FACS; Bradley J. Monk, MD, FACS, FACOG; Ritu Salani, MD, MBA

2.0 CME

2.0 CNE

38th Annual Miami Breast Cancer Conference®

03/04/2021 - 03/07/2021

Virtual Conference

Chair: Patrick I. Borgen, MD

26.75 CME

26.75 CNE

Community Practice Connections™: 5th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application

Expires on 02/26/2022

Arjun V. Balar, MD; Joshua Brody, MD; Naiyer Rizvi, MD; Mario Sznol, MD

2.0 CME

2.0 CNE

Postoperative Pain Management Through Opioid-Sparing Strategies for Patients With Breast Cancer
(7:00 pm - 8:00 pm EST)

03/04/2021

Live Webcast

Chair: Patrick I. Borgen, MD

1.0 CME

School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio

Expires on 02/22/2022

Joyce O’Shaughnessy, MD; Claudine Isaacs, MD; Terry P. Mamounas, MD, MPH, FACS

2.0 CME

Virtual Coffee Talk: Real-World Applications of PARP, PI3K, and HER2/3 in Breast Cancer Care
(7:00 am - 8:30 am EST)

03/05/2021

Live Webcast

Chair: Kevin Kalinsky, MD, MS

1.5 CME

Medical Crossfire®: Adverse Event Management Strategies to Maximize the Benefit of Novel Targeted Therapies for Patients With AML

Expires on 02/19/2022

Naval G. Daver, MD; Courtney DiNardo, MD, MSCE; Brian Jonas, MD, PhD, FACP; Andrew Wei, MBBS, PhD

1.5 CME

1.5 CNE

Integrating the Evidence for Risk-Based Individualization of Adjuvant Therapy for HER2-Positive Breast Cancer
(6:00 pm - 7:30 pm EST)

03/05/2021

Live Webcast

Chair: Debu Tripathy, MD

1.5 CME

Medical Crossfire®: Navigating the Advent of Novel Targeted and Immunotherapeutic Approaches in Cholangiocarcinoma

Expires on 02/19/2022

Andrew X. Zhu, MD, PhD; Tanios Bekaii-Saab, MD, FACP; Rondell P. Graham, MBBS

2.0 CME